Maricel Apuli SEC EDGAR Filings (CIK 0002058197)

SEC EDGAR filings, ownership reports, and insider transactions for Maricel Apuli.

Business address
3160 Porter Drive Suite 250, C/O Bridgebio Pharma, Inc., Palo Alto, CA, 94304
Top holdings (ownership)
BBIO
Get insider transactions for this reporting owner
Maricel Apuli has filed 9 SEC EDGAR filings since 27 Feb 2025

Latest Filings

Recent SEC filings for Maricel Apuli including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 16 Dec 2025 12 Dec 2025 001-38959
4 Open 4 document View SEC filing for 4 FORM 4 10 Dec 2025 08 Dec 2025 001-38959
4 Open 4 document View SEC filing for 4 FORM 4 18 Nov 2025 16 Nov 2025 001-38959
4 Open 4 document View SEC filing for 4 4 19 Aug 2025 16 Aug 2025 001-38959
4 Open 4 document View SEC filing for 4 4 11 Aug 2025 07 Aug 2025 001-38959
4 Open 4 document View SEC filing for 4 4 20 May 2025 16 May 2025 001-38959
4 Open 4 document View SEC filing for 4 4 06 May 2025 02 May 2025 001-38959
4 Open 4 document View SEC filing for 4 4 21 Mar 2025 19 Mar 2025 001-38959
3 Open 3 document View SEC filing for 3 3 27 Feb 2025 19 Feb 2025 001-38959

About this filer

Maricel Apuli files with the SEC under CIK 0002058197. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages